Author/Authors :
Kuruvilla, Oscar Henry Ford Health Systems - Department of Ophthalmology, USA , Munie, Metasebia Henry Ford Health Systems - Department of Ophthalmology, USA , Shah, Manthan Henry Ford Health Systems - Department of Ophthalmology, USA , Desai, Uday Henry Ford Health Systems - Department of Ophthalmology, USA , Miller, Joel A. Retina Consultants of Michigan, USA , Ober, Michael D. Henry Ford Health Systems - Department of Ophthalmology, USA , Ober, Michael D. Retina Consultants of Michigan, USA
Abstract :
Purpose: To report four cases of premacular hemorrhage secondary to valsalva retinopathy treated with Nd:YAG membranotomy and discuss techniques as well as the literature. Design: Retrospective case series. Methods: A retrospective review was conducted for four patients with vision obstructing hemorrhage secondary to valsalva retinopathy. These patients were all treated with Nd:YAG membranotomy. Results: Four patients with premacular hemorrhage secondary to valsalva retinopathy were treated with Nd:YAG laser creating a membranotomy to drain the hemorrhage. Power settings ranged from 1.7 to 3.8 mJ. Visual acuity at presentation ranged from 20/400 (1 patient) to count fingers (3 patients). Visual acuity improved in three out of four patients after laser treatment. Final visual acuity ranged from 20/20 to 20/30 in these three patients. One patient was lost to follow up after performing laser membranotomy and therefore visual acuity after treatment was not obtained. No complications were noted. Conclusion: Nd:YAG membranotomy is a non-invasive, office-based treatment option that may be successfully used to treat premacular hemorrhage secondary to valsalva retinopathy.
